Skip to main content
Clinical Trials/IRCT20190204042618N1
IRCT20190204042618N1
Recruiting
Phase 3

The Effect of oral Ibuprofen in term Infants with Patent Dactus Arteriosus

Shahre-kord University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahre-kord University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shahre-kord University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Gestational age more than 37 weeks
  • Age between 5 and 30 days old
  • Patent dactus arteriosus size more than 1\.5 mm detected by echocardiography

Exclusion Criteria

  • Having ductal dependent congenital heart disease
  • Creatinine more than 88\.5 micromol/l
  • Platelet count less than 50000

Outcomes

Primary Outcomes

Not specified

Similar Trials